(S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline

Product Overview

(S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline is a highly specialized chiral pharmaceutical intermediate characterized by its distinct stereochemistry and robust chemical stability. As a critical building block in modern medicinal chemistry, this compound serves as a foundational element for the synthesis of advanced therapeutic agents, particularly within the urological sector. Our manufacturing process ensures exceptional enantiomeric purity, making it an ideal candidate for complex organic synthesis routes requiring precise stereocontrol.

We adhere to strict quality management systems to guarantee consistency across every batch. This product is specifically engineered to meet the rigorous demands of pharmaceutical research and development, providing a reliable foundation for the production of high-value active pharmaceutical ingredients (APIs).

Technical Specifications

Our production facility utilizes advanced analytical techniques to verify all physical and chemical parameters. The following table outlines the standard specifications for this intermediate:

Applications and Usage

This chiral intermediate is primarily utilized in the synthesis of Solifenacin succinate, a well-known therapeutic agent used in the management of overactive bladder conditions. The specific (S)-enantiomer configuration is crucial for the biological activity and safety profile of the final pharmaceutical product. Beyond this primary application, it serves as a versatile scaffold for developing novel neurological and urological therapeutics.

Key advantages for process chemists include:

• High enantiomeric excess ensuring minimal downstream purification.
• Excellent solubility profile suitable for various reaction conditions.
• Stable under standard storage conditions, facilitating long-term inventory management.
• Compatible with diverse synthetic pathways for API manufacturing.

Quality Assurance and Safety

Quality is paramount in pharmaceutical intermediate manufacturing. Each production batch undergoes comprehensive testing using High-Performance Liquid Chromatography (HPLC) and Nuclear Magnetic Resonance (NMR) spectroscopy. We provide a detailed Certificate of Analysis (COA) with every shipment, documenting all critical quality attributes.

Regarding safety, this compound should be handled in accordance with standard laboratory safety protocols. Personnel should use appropriate personal protective equipment (PPE) including gloves and safety goggles. Operations should be conducted in a well-ventilated environment to minimize exposure to dust or vapors.

Storage and Packaging

To maintain optimal quality, the product must be stored in tightly closed containers within a cool, dry, and well-ventilated area. It should be kept away from incompatible substances such as strong oxidizing agents. Standard packaging includes 25kg cardboard drums, though custom packaging solutions are available to meet specific logistical requirements. Proper storage ensures the material retains its specified purity and physical characteristics over extended periods.